Terms: = Leukemia AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Prognosis
23 results:
1. RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses.
Adnan Awad S; Dufva O; Ianevski A; Ghimire B; Koski J; Maliniemi P; Thomson D; Schreiber A; Heckman CA; Koskenvesa P; Korhonen M; Porkka K; Branford S; Aittokallio T; Kankainen M; Mustjoki S
Leukemia; 2021 Apr; 35(4):1087-1099. PubMed ID: 32782381
[TBL] [Abstract] [Full Text] [Related]
2. PBX3 Promotes Tumor Growth and Angiogenesis via Activation of AT1R/vegfr2 Pathway in Papillary Thyroid Carcinoma.
Chen Q; Yu WY; Zhang HH; Zhang SZ; Fang J; Wu F; Ying HZ; Yu CH
Biomed Res Int; 2020; 2020():8954513. PubMed ID: 32047817
[TBL] [Abstract] [Full Text] [Related]
3. Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival.
Guillem V; Calabuig M; Brunet S; Esteve J; Escoda L; Gallardo D; Ribera JM; Queipo de Llano MP; Arnan M; Pedro C; Amigo ML; Martí-Tutusaus JM; García-Guiñón A; Bargay J; Sampol A; Salamero O; Font L; Talarn C; Hoyos M; Díaz-Beyá M; Garrido A; Navarro B; Nomdédeu J; Sierra J; Tormo M
Leuk Lymphoma; 2018 Oct; 59(10):2383-2393. PubMed ID: 29345176
[TBL] [Abstract] [Full Text] [Related]
4. Midostaurin for the treatment of adult patients with newly diagnosed acute myeloid leukemia that is FLT3 mutation-positive.
Garcia JS; Percival ME
Drugs Today (Barc); 2017 Oct; 53(10):531-543. PubMed ID: 29286055
[TBL] [Abstract] [Full Text] [Related]
5. The distribution and potential prognostic value of SMAD protein expression in chronic lymphocytic leukemia.
Witkowska M; Majchrzak A; Cebula-Obrzut B; Wawrzyniak E; Robak T; Smolewski P
Tumour Biol; 2017 Mar; 39(3):1010428317694551. PubMed ID: 28349818
[TBL] [Abstract] [Full Text] [Related]
6. Ponatinib reduces viability, migration, and functionality of human endothelial cells.
Gover-Proaktor A; Granot G; Shapira S; Raz O; Pasvolsky O; Nagler A; Lev DL; Inbal A; Lubin I; Raanani P; Leader A
Leuk Lymphoma; 2017 Jun; 58(6):1455-1467. PubMed ID: 27733071
[TBL] [Abstract] [Full Text] [Related]
7. [The importance of taking late cardiovascular toxicity induced by TKI into consideration in patients with CML].
Takahashi N
Rinsho Ketsueki; 2016; 57(10):1956-1961. PubMed ID: 27725593
[TBL] [Abstract] [Full Text] [Related]
8. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of vascular endothelial growth factor expression in adult patients with acute myeloid leukemia: a meta-analysis.
Guo B; Liu Y; Tan X; Cen H
Leuk Lymphoma; 2013 Jul; 54(7):1418-25. PubMed ID: 23157271
[TBL] [Abstract] [Full Text] [Related]
10. Role of VEGF/vegfr in the pathogenesis of leukemias and as treatment targets (Review).
Song G; Li Y; Jiang G
Oncol Rep; 2012 Dec; 28(6):1935-44. PubMed ID: 22993103
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic impact of δ-like ligand 4 and Notch1 in acute myeloid leukemia.
Zhang J; Ma D; Ye J; Zang S; Lu F; Yang M; Qu X; Sun X; Ji C
Oncol Rep; 2012 Oct; 28(4):1503-11. PubMed ID: 22858860
[TBL] [Abstract] [Full Text] [Related]
12. Effective treatment of advanced cholangiocarcinoma by hepatic arterial infusion chemotherapy combination with sorafenib: one case report from China.
Qun W; Tao Y
Hepatogastroenterology; 2010; 57(99-100):426-9. PubMed ID: 20698202
[TBL] [Abstract] [Full Text] [Related]
13. Additive effect of PTK787/ZK 222584, a potent inhibitor of vegfr phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia.
Barbarroja N; Torres LA; Luque MJ; Carretero RM; Valverde-Estepa A; Lopez-Sanchez LM; Rodriguez-Ariza A; Velasco F; Torres A; López-Pedrera C
Exp Hematol; 2009 Jun; 37(6):679-91. PubMed ID: 19463770
[TBL] [Abstract] [Full Text] [Related]
14. Quantification of VEGF isoforms and vegfr transcripts by qRT-PCR and their significance in acute myeloid leukemia.
Mourah S; Porcher R; Lescaille G; Rousselot P; Podgorniak MP; Labarchède G; Naimi B; Medioni J; Dombret H; Calvo F
Int J Biol Markers; 2009; 24(1):22-31. PubMed ID: 19404919
[TBL] [Abstract] [Full Text] [Related]
15. Addition of PTK787/ZK 222584 can lower the dosage of amsacrine to achieve equal amounts of acute myeloid leukemia cell death.
Weidenaar AC; de Jonge HJ; Fidler V; ter Elst A; Meeuwsen-de Boer T; Douwes J; Bouma-ter Steege JC; Hählen K; Kamps WA; de Bont ES
Anticancer Drugs; 2008 Jan; 19(1):45-54. PubMed ID: 18043129
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical importance of angiogenesis and angiogenic factors in oncohematology].
Grosicki S; Grosicka A; Hołowiecki J
Wiad Lek; 2007; 60(1-2):39-46. PubMed ID: 17607967
[TBL] [Abstract] [Full Text] [Related]
17. Vascular endothelial growth factor C--a potent risk factor in childhood acute lymphoblastic leukaemia: an immunocytochemical approach.
Nowicki M; Ostalska-Nowicka D; Kaczmarek E; Miskowiak B; Witt M
Histopathology; 2006 Aug; 49(2):170-7. PubMed ID: 16879394
[TBL] [Abstract] [Full Text] [Related]
18. Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome.
Roboz GJ; Giles FJ; List AF; Cortes JE; Carlin R; Kowalski M; Bilic S; Masson E; Rosamilia M; Schuster MW; Laurent D; Feldman EJ
Leukemia; 2006 Jun; 20(6):952-7. PubMed ID: 16617323
[TBL] [Abstract] [Full Text] [Related]
19. The anti-angiogenesis agent, AG-013736, has minimal activity in elderly patients with poor prognosis acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Giles FJ; Bellamy WT; Estrov Z; O'Brien SM; Verstovsek S; Ravandi F; Beran M; Bycott P; Pithavala Y; Steinfeldt H; Reich SD; List AF; Yee KW
Leuk Res; 2006 Jul; 30(7):801-11. PubMed ID: 16332390
[TBL] [Abstract] [Full Text] [Related]
20. Placenta growth factor stimulates the growth of Philadelphia chromosome positive acute lymphoblastic leukemia cells by both autocrine and paracrine pathways.
Ikai T; Miwa H; Shikami M; Hiramatsu A; Tajima E; Yamamoto H; Imai N; Hattori A; Nishii K; Miura K; Satoh A; Itoh M; Imamura A; Mihara H; Katoh Y; Nitta M
Eur J Haematol; 2005 Oct; 75(4):273-9. PubMed ID: 16146532
[TBL] [Abstract] [Full Text] [Related]
[Next]